Cargando…
Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
BACKGROUND: Hypertension (HTN) treatment has remained insufficient. New modalities such as “Symplicity method” for the treatment of HTN are a priority, especially in patients with resistant hypertension. In this study, we describe our first experience with a novel percutaneous treatment modality, wi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653263/ https://www.ncbi.nlm.nih.gov/pubmed/23696764 |
_version_ | 1782269403461582848 |
---|---|
author | Honarvar, Mehrdad Amirpour, Afshin Pourmoghaddas, Masoud |
author_facet | Honarvar, Mehrdad Amirpour, Afshin Pourmoghaddas, Masoud |
author_sort | Honarvar, Mehrdad |
collection | PubMed |
description | BACKGROUND: Hypertension (HTN) treatment has remained insufficient. New modalities such as “Symplicity method” for the treatment of HTN are a priority, especially in patients with resistant hypertension. In this study, we describe our first experience with a novel percutaneous treatment modality, without using Symplicity catheter. METHODS: 30 Patients who were resistant to at least three types of antihypertensive medical therapy were selected. Patients received percutaneous renal artery denervation, without Symplicity catheter method, and were followed up for 1 week, 1, 3, and 6 months later after treatment. Ambulatory 24-hour blood pressure (BP) Holter was performed 1 week before intervention and after 1 month. The primary outcome was change in 24-hour ambulatory BP and change in office and home-based BP measurements. RESULTS: The mean age of the studied patients was 52 ± 15.4 years and 43.3% (n = 13) were female. Systolic and diastolic BP at baseline was 163 ± 17.2 and 95 ± 8.2 mmHg, respectively. Patients took 3.6 ± 1.3 hypertensive medications. Systolic and diastolic BP at 1-week, 1-month, 3-month and 6-month after renal denervation significantly decreased compared to the baseline (P < 0.0001). Average BP derived from 24-hour ambulatory BP monitoring changed in parallel with office-based BP measurements. Most of patients (50%) who underwent renal denervation had reductions of 10 mmHg or greater in systolic BP and 56.7% of them had reductions of 5 mmHg or greater in diastolic BP. 33.3% of patients also achieved the target of systolic BP less than 140 mmHg and 60% achieved the target of diastolic BP less than 90 mmHg. No patients showed vascular damage at final angiography. CONCLUSION: Catheter based renal ablation was associated with a significant reduction in both systolic and diastolic BP, on top of maximal medical therapy, which persisted throughout 6 months follow-up in the first-in-man study without the Symplicity catheter. |
format | Online Article Text |
id | pubmed-3653263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-36532632013-05-21 Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience Honarvar, Mehrdad Amirpour, Afshin Pourmoghaddas, Masoud ARYA Atheroscler Original Article BACKGROUND: Hypertension (HTN) treatment has remained insufficient. New modalities such as “Symplicity method” for the treatment of HTN are a priority, especially in patients with resistant hypertension. In this study, we describe our first experience with a novel percutaneous treatment modality, without using Symplicity catheter. METHODS: 30 Patients who were resistant to at least three types of antihypertensive medical therapy were selected. Patients received percutaneous renal artery denervation, without Symplicity catheter method, and were followed up for 1 week, 1, 3, and 6 months later after treatment. Ambulatory 24-hour blood pressure (BP) Holter was performed 1 week before intervention and after 1 month. The primary outcome was change in 24-hour ambulatory BP and change in office and home-based BP measurements. RESULTS: The mean age of the studied patients was 52 ± 15.4 years and 43.3% (n = 13) were female. Systolic and diastolic BP at baseline was 163 ± 17.2 and 95 ± 8.2 mmHg, respectively. Patients took 3.6 ± 1.3 hypertensive medications. Systolic and diastolic BP at 1-week, 1-month, 3-month and 6-month after renal denervation significantly decreased compared to the baseline (P < 0.0001). Average BP derived from 24-hour ambulatory BP monitoring changed in parallel with office-based BP measurements. Most of patients (50%) who underwent renal denervation had reductions of 10 mmHg or greater in systolic BP and 56.7% of them had reductions of 5 mmHg or greater in diastolic BP. 33.3% of patients also achieved the target of systolic BP less than 140 mmHg and 60% achieved the target of diastolic BP less than 90 mmHg. No patients showed vascular damage at final angiography. CONCLUSION: Catheter based renal ablation was associated with a significant reduction in both systolic and diastolic BP, on top of maximal medical therapy, which persisted throughout 6 months follow-up in the first-in-man study without the Symplicity catheter. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2013-01 /pmc/articles/PMC3653263/ /pubmed/23696764 Text en © 2013 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Honarvar, Mehrdad Amirpour, Afshin Pourmoghaddas, Masoud Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience |
title | Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience |
title_full | Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience |
title_fullStr | Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience |
title_full_unstemmed | Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience |
title_short | Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience |
title_sort | renal ablation for treatment of hypertension without symplicity catheter: the first human experience |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653263/ https://www.ncbi.nlm.nih.gov/pubmed/23696764 |
work_keys_str_mv | AT honarvarmehrdad renalablationfortreatmentofhypertensionwithoutsymplicitycatheterthefirsthumanexperience AT amirpourafshin renalablationfortreatmentofhypertensionwithoutsymplicitycatheterthefirsthumanexperience AT pourmoghaddasmasoud renalablationfortreatmentofhypertensionwithoutsymplicitycatheterthefirsthumanexperience |